/PRNewswire-PRWeb/ -- Maintaining asthma medication and asthma control leads to safer perinatal outcomes for pregnant women according to new research published...
"women with asthma who continued to use inhaled corticosteroids during pregnancy had decreased odds of preterm delivery" Post this According to the research, asthma affects 5-13% of pregnant women with many women requiring daily pharmacotherapy to achieve asthma control, however, adherence to medication often decreases during pregnancy. Maternal asthma leaves pregnant women at increased risk for adverse perinatal outcomes including preeclampsia, gestational diabetes, placental abruption, obstetric hemorrhage and placenta previa, and the risk increases with asthma exacerbations. Maintaining asthma medication during pregnancy can reduce preterm delivery and aid in achieving improved maternal and neonatal outcomes according to the study. To understand the association between the use of asthma medication on asthma exacerbation and maternal and neonatal outcomes, researchers used linked population-based administrative databases from Alberta, Canada, spanning from 2012 to 2018 to categorize pregnant women with asthma based on their asthma medication…
The American Academy of Allergy, Asthma & Immunology (AAAAI)